| Serial Number | 79238525 |
| Word Mark | NMD PHARMA NEUROMUSCULAR DISORDERS |
| Filing Date | Friday, May 18, 2018 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, July 23, 2019 |
| Registration Number | 5809155 |
| Registration Date | Tuesday, July 23, 2019 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, May 7, 2019 |
| Description of Mark | The mark consists of the letters "NMD" in dark grey with a green diamond over the letter "M" followed by the word "PHARMA" in light grey over the wording "NEUROMUSCULAR DISORDERS" in light grey. |
| Certificate of Correction for Registration | In the statement, in the heading, " International Class 5 " is corrected per the restriction and the fnote dated 11/14/2019. |
| Goods and Services | Chemical-pharmaceutical preparations for the treatment of rare and genetic diseases; chemical-pharmaceutical preparations for the treatment of neurodegenerative diseases; chemical-pharmaceutical preparations for the treatment of neuromuscular disorders; chemical-pharmaceutical preparations that strengthen neuromuscular transmission and muscle function in patients with neuromuscular disorders; chemical-pharmaceutical preparations for the treatment of neuromuscular disorders caused by compromised skeletal muscle excitability; diagnostic preparations for medical purposes; reagents for medical purposes [ and for research ] ; preparations for analysis for medical [ and research ] purposes; pharmaceutical and medical preparations for the treatment of rare and genetic diseases; pharmaceutical and medical preparations for the treatment of neurodegenerative diseases; pharmaceutical and medical preparations for the treatment of neuromuscular disorders; pharmaceutical and medical preparations that strengthen neuromuscular transmission and muscle function in patients with neuromuscular disorders; pharmaceutical and medical preparations for acute hospital care, namely, chemical-pharmaceutical preparations for the reversal of neuromuscular blockade, chemical-pharmaceutical preparations for the treatment of intensive care unit acquired muscle weakness, chemical-pharmaceutical preparations for the treatment of neuromuscular disorders caused by infections |
| Indication of Colors claimed | The color(s) dark grey, light grey, and green is/are claimed as a feature of the mark. |
| Disclaimer with Predetermined Text | "PHARMA" AND "NEUROMUSCULAR DISORDERS" |
| Goods and Services | Scientific and technological services and research, namely, research in the field of medicine and the development of pharmaceutical preparations; industrial analysis and research services in the field of development of pharmaceutical preparations, and in the field of identification of drug candidates; drug discovery services; basic research and clinical research, hereunder in the field of medicine and vaccine development; development of medical treatments related to rare and genetic diseases; development of medical treatments related to neurodegenerative diseases; development of medical treatments related to neuromuscular disorders; development of medical treatments that strengthen neuromuscular transmission and muscle function in patients with neuromuscular disorders; development of medical treatments for acute hospital care |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, August 15, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, August 15, 2018 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | NMD Pharma A/S |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | DK |
| Party Name | NMD Pharma A/S |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | DK |
| Party Name | NMD Pharma A/S |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | DK |
| Event Date | Event Description |
| Saturday, September 9, 2023 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Thursday, September 3, 2020 | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE |
| Sunday, July 26, 2020 | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED |
| Friday, December 6, 2019 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Thursday, November 21, 2019 | CORRECTION UNDER SECTION 7 ¿ PROCESSED |
| Thursday, November 21, 2019 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Thursday, November 14, 2019 | FINAL DISPOSITION NOTICE SENT TO IB |
| Thursday, November 14, 2019 | LIMITATION FROM THE IB EXAMINED AND ENTERED |
| Thursday, November 14, 2019 | FINAL DISPOSITION PROCESSED |
| Wednesday, October 23, 2019 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Friday, August 23, 2019 | LIMITATION OF GOODS RECEIVED FROM IB |
| Tuesday, July 23, 2019 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, May 7, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 7, 2019 | PUBLISHED FOR OPPOSITION |
| Friday, May 3, 2019 | NOTIFICATION PROCESSED BY IB |
| Tuesday, April 30, 2019 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, April 17, 2019 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, April 17, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, April 17, 2019 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Monday, March 18, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, March 18, 2019 | EXAMINER'S AMENDMENT ENTERED |
| Monday, March 18, 2019 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, March 18, 2019 | EXAMINERS AMENDMENT E-MAILED |
| Monday, March 18, 2019 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, March 5, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, March 4, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, March 4, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, October 13, 2018 | REFUSAL PROCESSED BY IB |
| Saturday, September 22, 2018 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, September 22, 2018 | REFUSAL PROCESSED BY MPU |
| Tuesday, September 18, 2018 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, September 17, 2018 | NON-FINAL ACTION WRITTEN |
| Monday, September 10, 2018 | ASSIGNED TO EXAMINER |
| Tuesday, August 21, 2018 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, August 15, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, August 9, 2018 | SN ASSIGNED FOR SECT 66A APPL FROM IB |